Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.

A. Calin, Robert (Rob) Bennett, S. Sukhupunyaraksa, A. L. Goldman, H. E. Montoya, W. M. O'Brien, V. J. Giuliano, F. R. Schmid, R. F. Willkens, H. Y. Sakofsky

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

Original languageEnglish (US)
Pages (from-to)153-157
Number of pages5
JournalJournal of Rheumatology
Volume4
Issue number2
StatePublished - Jun 1977
Externally publishedYes

Fingerprint

Ketoprofen
Ibuprofen
Rheumatoid Arthritis
Non-Steroidal Anti-Inflammatory Agents
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Calin, A., Bennett, R. R., Sukhupunyaraksa, S., Goldman, A. L., Montoya, H. E., O'Brien, W. M., ... Sakofsky, H. Y. (1977). Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. Journal of Rheumatology, 4(2), 153-157.

Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. / Calin, A.; Bennett, Robert (Rob); Sukhupunyaraksa, S.; Goldman, A. L.; Montoya, H. E.; O'Brien, W. M.; Giuliano, V. J.; Schmid, F. R.; Willkens, R. F.; Sakofsky, H. Y.

In: Journal of Rheumatology, Vol. 4, No. 2, 06.1977, p. 153-157.

Research output: Contribution to journalArticle

Calin, A, Bennett, RR, Sukhupunyaraksa, S, Goldman, AL, Montoya, HE, O'Brien, WM, Giuliano, VJ, Schmid, FR, Willkens, RF & Sakofsky, HY 1977, 'Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.', Journal of Rheumatology, vol. 4, no. 2, pp. 153-157.
Calin A, Bennett RR, Sukhupunyaraksa S, Goldman AL, Montoya HE, O'Brien WM et al. Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. Journal of Rheumatology. 1977 Jun;4(2):153-157.
Calin, A. ; Bennett, Robert (Rob) ; Sukhupunyaraksa, S. ; Goldman, A. L. ; Montoya, H. E. ; O'Brien, W. M. ; Giuliano, V. J. ; Schmid, F. R. ; Willkens, R. F. ; Sakofsky, H. Y. / Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. In: Journal of Rheumatology. 1977 ; Vol. 4, No. 2. pp. 153-157.
@article{8c22bffd65e94532a5d72bacdef4ca01,
title = "Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.",
abstract = "A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.",
author = "A. Calin and Bennett, {Robert (Rob)} and S. Sukhupunyaraksa and Goldman, {A. L.} and Montoya, {H. E.} and O'Brien, {W. M.} and Giuliano, {V. J.} and Schmid, {F. R.} and Willkens, {R. F.} and Sakofsky, {H. Y.}",
year = "1977",
month = "6",
language = "English (US)",
volume = "4",
pages = "153--157",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "2",

}

TY - JOUR

T1 - Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.

AU - Calin, A.

AU - Bennett, Robert (Rob)

AU - Sukhupunyaraksa, S.

AU - Goldman, A. L.

AU - Montoya, H. E.

AU - O'Brien, W. M.

AU - Giuliano, V. J.

AU - Schmid, F. R.

AU - Willkens, R. F.

AU - Sakofsky, H. Y.

PY - 1977/6

Y1 - 1977/6

N2 - A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

AB - A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

UR - http://www.scopus.com/inward/record.url?scp=0017499876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017499876&partnerID=8YFLogxK

M3 - Article

C2 - 328880

AN - SCOPUS:0017499876

VL - 4

SP - 153

EP - 157

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 2

ER -